Alzheimer’s Association International Conference | July 16-20, 2023 | Amsterdam, Netherlands and Online
AAIC 2022 at a Glance
2022 Press Releases
- Alzheimer’s Association Statement on New Clinical Trial Results Reported at AAIC 2022
- Experiences of Racism Associated with Poor Memory, Increased Cognitive Decline
News Highlights
Plenary Sessions
Carole Escartin, Ph.D.: Astrocytes in Neurodegenerative Disorders
Krista Lanctôt, Ph.D.: Apathy in Neurodegenerative Diseases
Thomas Beach, M.D., Ph.D.: Neuropathology in the Era of In-Vivo Biomarkers
Margot Kushel, M.D: Aging in Homeless Populations
Francisco Lopera, M.D.: The Role of Biomarkers in Preventative Clinical Trials in Alzheimer's Disease: Perspectives from a South American Country
Sharon K. Inouye, M.D., MPH: The Interface of Delirium and Dementia
Frank M. Longo, M.D., Ph.D.: Next-Generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Linda Lam, MBChB, M.D.: Non-Pharmacological Care, Behavior Change, MCI
Rakez Kayed, Ph.D.: Tau Oligomer Induced HMGB1 Release Contributes to Cellular Senescence and Neuropathology Linked to Alzheimer’s Disease and Frontotemporal Dementia
HIGHLIGHTS FROM AAIC 2022
Program
Over 10,000 attendees joined the world's largest and most influential dementia research conference.
Abstracts
AAIC 2022 featured more than 3,000 posters. Abstracts will be published in a future issue of Alzheimer's & Dementia®: The Journal of the Alzheimer's Association.
View the Abstracts
Awards
Congratulations to the 2022 awardees, who were honored for their significant contributions to the field of Alzheimer’s disease and dementia science.
Meet the Awardees
Follow
©
2022
Alzheimer's Association®.
All rights reserved.
Alzheimer's Association is a not-for-profit 501(c)(3) organization.
Security and Privacy Policy | alz.org
Security and Privacy Policy | alz.org
> 1200px
lg > 992px
md > 768px
sm < 767px
xs
lg > 992px
md > 768px
sm < 767px
xs